Sequent Scientific, an animal health firm, on Friday said it has appointed Rajaram Narayanan as MD and CEO for five years, with effect from April 11, 2022.
Narayanan replaces Manish Gupta who has put in his papers.
The company's board, pursuant to the recommendation by the nomination and remuneration committee, approved the appointment of Narayanan as the MD and CEO for five years with effect from April 11, 2022, subject to the approval of the shareholders, Sequent Scientific said in a regulatory filing.
Narayanan, who has served in senior leadership roles across the pharmaceutical, consumer goods and services industries, succeeds Gupta who will step down effective April 10, 2022, after serving as the company's MD and CEO for the past eight years, it added.
Narayanan served as Sanofi India MD prior to joining Sequent.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.